Cision PR Newswire

AccidentAccidentAir PollutionAll NewsAnnoucementArgricultureArtASEANBook

AI Memory & Storage: The 5th GMIF2026 Innovation Summit Successfully Concludes in Shenzhen

SHENZHEN, China, Sept. 26, 2026 /PRNewswire/ -- On September 23, the 5th GMIF2026 Innovation Summit successfully concluded at the Renaissance Shenzhen Bay Hotel. Co-hosted by the Shenzhen Memory Industry Association (SMIA) and School of Integrated Circuits at Peking University, the summit, themed "The Future Built on AI Memory and...

2026 Beijing International Week for Science Literacy Launched in Beijing

BEIJING, Sept. 27, 2026 /PRNewswire/ -- The 2026 Beijing International Week for Science Literacy...
Cision PR Newswire

2026 IMS | IASO Bio Presented FUCASO China Real-World Data

--- In a large China real-world study of 281 heavily pretreated, predominantly high-risk patients...
Cision PR Newswire

2026 IMS | IASO Bio Presented First-in-Human Data of BCMA-Targeted In Vivo CAR-T Cell Therapy IASO206

— Late-breaking oral presentation of first-in-human data (LBA-11) showed that a single intravenous infusion...
Cision PR Newswire

SEGI FRESH UNVEILS NEW STORE CONCEPT AND REFRESHED BRAND IDENTITY IN BIDOR

BIDOR, Malaysia, Sept. 26, 2026 /PRNewswire/ -- Segi Fresh, Malaysia's Top 1 Fresh Mart,...
Cision PR Newswire

Blokees made its debut at CCXP México 2025, Officially Enters México Market

SHANGHAI, June 1, 2025 /PRNewswire/ -- On May 30, 2025, the most influential pop culture exhibition in Latin America, CCXP Mexico 2025, grandly opened...

InxMed Announces Promising Phase Ib/II Clinical Data for Ifebemtinib + KRAS G12C inhibitor in KRAS G12C-Mutant Solid Tumors at ASCO 2025

NANJING, China, June 1, 2025 /PRNewswire/ -- InxMed Co., Ltd, a clinical-stage biotechnological company, pioneering therapies to transform cancer treatment, released latest clinical data from a Phase Ib/II clinical...

Tianfu Rapoil Shines at Hong Kong Hometown Market Carnival

HONG KONG, June 1, 2025 /PRNewswire/ -- This is a report from Xinhuanet: Co-organized by 30 provincial-level hometown associations in Hong Kong, the...

ASCO 2025 Oral Presentation: Innovent Biologics Announces Updated Data of IBI363 (First-in-class PD-1/IL-2α -bias Bispecific Antibody Fusion Protein) from Phase 1 and 2 Clinical...

SAN FRANCISCO and SUZHOU, China, June 1, 2025 /PRNewswire/ -- Innovent Biologics, Inc (Suzhou) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and...

Zeekr Group Announces May 2025 Delivery Update

HANGZHOU, China, June 1, 2025 /PRNewswire/ -- ZEEKR Intelligent Technology Holding Limited ("Zeekr Group" or the "Company") (NYSE: ZK), the world's leading premium new...

Breakthrough Clinical Data for LBL-024 in First-Line Treatment of Advanced EP-NEC Unveiled at 2025 ASCO Oral Session

NANJING, China, May 31, 2025 /PRNewswire/ -- Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs") today announced the presentation of groundbreaking clinical data from a...
1...3,2803,2813,282...4,393Page 3,281 of 4,393